Literature DB >> 32387856

Are polyploid giant cancer cells in high grade serous carcinoma of the ovary blastomere-like cancer stem cells?

Alireza Salem1, Karen Pinto1, Meghan Koch1, Jinsong Liu2, Elvio G Silva3.   

Abstract

Polyploid giant cancer cells, either multinucleated or mononucleated, in high grade serous carcinoma of the ovary have been previously recognized. Different theories including degenerative changes or an important step in the development of high grade serous carcinoma have been proposed. Here we investigate possible explanations for the presence of polyploid giant cancer cells in high grade serous carcinoma. We reviewed 33 cases of ovarian high grade serous carcinoma (12 stage I, 7 stage II, and 14 stage III). We counted the number of polyploid giant cancer cells in 20 consecutive 10× fields. In 11 cases where polyploid giant cancer cells were easily found, immunohistochemistry for Ki67, p53, and OCT 3/4 was performed. Patients with polyploid giant cancer cells were older than those without. Polyploid giant cancer cells were more frequent in stage I lesions (75%) than in stages II or III (57% in both) and less frequent in metastases compared with primary ovarian tumors. Mitotic figures were present in regular sized cells but were absent in polyploid giant cancer cells. OCT3/4 was negative in all cases assessed. In 8 cases, more than 70% of the mononuclear cells were positive for Ki-67, similar to the percentage of Ki-67 positive cells in polyploid giant cancer cells. p53 had a perfect correlation in regular sized cancer cells and in polyploid giant cancer cells. Polyploid giant cancer cells are neither degenerative cells nor traditional cancer stem cells but most probably represent an intermediate step between stem cells and mature tumor cells formed by endoreplication.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Blastomere-like cancer stem cells; Endoreplication; High grade serous carcinoma; Multinucleated and giant tumor cells; Ovary; Polyploid giant cancer cells

Mesh:

Year:  2020        PMID: 32387856     DOI: 10.1016/j.anndiagpath.2020.151505

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  4 in total

Review 1.  The life cycle of polyploid giant cancer cells and dormancy in cancer: Opportunities for novel therapeutic interventions.

Authors:  Jinsong Liu; Na Niu; Xiaoran Li; Xudong Zhang; Anil K Sood
Journal:  Semin Cancer Biol       Date:  2021-10-17       Impact factor: 15.707

2.  Mutation in SF3B1 gene promotes formation of polyploid giant cells in Leukemia cells.

Authors:  Sanjay Mukherjee; Abdullah Mahmood Ali; Vundavalli V Murty; Azra Raza
Journal:  Med Oncol       Date:  2022-04-28       Impact factor: 3.738

3.  Cancer recurrence and lethality are enabled by enhanced survival and reversible cell cycle arrest of polyaneuploid cells.

Authors:  K J Pienta; E U Hammarlund; J S Brown; S R Amend; R M Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 11.205

4.  Autophagy modulating therapeutics inhibit ovarian cancer colony generation by polyploid giant cancer cells (PGCCs).

Authors:  Robert R Bowers; Maya F Andrade; Christian M Jones; Shai White-Gilbertson; Christina Voelkel-Johnson; Joe R Delaney
Journal:  BMC Cancer       Date:  2022-04-14       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.